Leaderboards/Nail Diseases and Treatments

Nail Diseases and Treatments

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Diana M. Proctor
The University of Texas MD Anderson Cancer Center
2
Maria Siopi
National and Kapodistrian University of Athens
3
Xue Kong
Chinese Academy of Medical Sciences & Peking Union Medical College
4
Darian J. Santana
St. Jude Children's Research Hospital
5
Mohammed Muqtader Ahmed
Prince Sattam Bin Abdulaziz University
6
Junichiro Hiruma
Otsuka (Japan)
7
Chowdhury Mobaswar Hossain
Maulana Abul Kalam Azad University of Technology, West Bengal
8
Stephen K Stacey
Mayo Clinic Health System
9
Connie Cañete‐Gibas
The University of Texas Health Science Center at San Antonio
10
M.E. Klinger
University of Zurich

Rising Stars Papers

1
Antioxidant and Anti-inflammatory Applications of <i>Aerva persica</i> Aqueous-Root Extract-Mediated Synthesis of ZnO Nanoparticles
ACS Omega|2024
36 cit.
2
Evaluation of the Vitek 2 system for antifungal susceptibility testing of <i>Candida auris</i> using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance
Journal of Clinical Microbiology|2024
32 cit.
3
Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023
Eurosurveillance|2024
29 cit.
4
Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes
Nature|2025
28 cit.
5
Antifungal resistance of the <i>Trichophyton mentagrophytes/Trichophyton interdigitale</i> species complex: Insights from the China Antifungal Resistance Dermatophytes Surveillance network Study (CARDS)
Journal of the European Academy of Dermatology and Venereology|2025
9 cit.
6
Development of treatment strategies by comparing the minimum inhibitory concentrations and minimum fungicidal concentrations of azole drugs in dermatophytes
The Journal of Dermatology|2024
8 cit.
7
Evaluation of the MIC test strips for antifungal susceptibility testing of <i>Candidozyma auris</i> ( <i>Candida auris</i> ) using a representative international collection of isolates
Journal of Clinical Microbiology|2025
8 cit.
8
Malassezia polysorbatinonusus sp. nov., a Novel Isolate from a Japanese Patient with Seborrheic Dermatitis
Mycopathologia|2025
7 cit.
9
Design and fabrication of 3D-printed gastric floating tablets of captopril: effect of geometry and thermal crosslinking of polymer on floating behavior and drug release
Pharmaceutical Development and Technology|2024
4 cit.
10
A Candida auris-Specific Adhesin, Scf1, Governs Surface Association, Colonization, and Virulence
Deep Blue (University of Michigan)|2024
4 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Shari R. Lipner
Cornell University
2
Silke Uhrlaß
Marienhospital Bottrop
3
Jeniel E. Nett
University of Wisconsin–Madison
4
Cornelia Wiegand
Klinik und Poliklinik für Hautkrankheiten
5
Karlyn D. Beer
Seattle Pacific University
6
Shady A. Swidan
British University in Egypt
7
Ali M. Nasr
Suez University
8
Shraddha Uprety
Chitwan Medical College
9
Menghui Zhang
Fuzhou University
10
Xiaolong Zhou
Hunan University of Traditional Chinese Medicine

Emerging Leaders Papers

1
Nano-bio finishing of cotton fabric with quaternized chitosan Schiff base-TiO2-ZnO nanocomposites for antimicrobial and UV protection applications
European Polymer Journal|2022
69 cit.
2
Mechanisms of pathogenicity for the emerging fungus Candida auris
PLoS Pathogens|2023
65 cit.
3
Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability
Pharmaceutics|2022
42 cit.
4
Upgrading the Transdermal Biomedical Capabilities of Thyme Essential Oil Nanoemulsions Using Amphiphilic Oligochitosan Vehicles
Pharmaceutics|2022
40 cit.
5
Ex Vivo Human and Porcine Skin Effectively Model<i>Candida auris</i>Colonization, Differentiating Robust and Poor Fungal Colonizers
The Journal of Infectious Diseases|2022
37 cit.
6
Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program
Journal of Fungi|2023
33 cit.
7
Readability and Health Literacy Scores for ChatGPT-Generated Dermatology Public Education Materials: Cross-Sectional Analysis of Sunscreen and Melanoma Questions
JMIR Dermatology|2024
32 cit.
8
Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model
MicrobiologyOpen|2022
31 cit.
9
Induction of psoriasis- and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix
Scientific Reports|2023
31 cit.
10
Dual-attention transformer-based hybrid network for multi-modal medical image segmentation
Scientific Reports|2024
31 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Arturo Casadevall
Johns Hopkins University
2
Tania C. Sorrell
The University of Sydney
3
David A. Stevens
Stanford University
4
Julia A. Segre
National Human Genome Research Institute
5
Heidi H. Kong
National Institutes of Health
6
John E. Bennett
National Institute of Allergy and Infectious Diseases
7
Richard C. Summerbell
Public Health Ontario
8
Joseph Heitman
Duke University
9
Thomas L. Dawson
Agency for Science, Technology and Research
10
Michel Monod
University Hospital of Lausanne

Current Senior Leaders Papers

1
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases|2008
4.9k cit.
2
Topographical and Temporal Diversity of the Human Skin Microbiome
Science|2009
3k cit.
3
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2016
2.8k cit.
4
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2010
2.7k cit.
5
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Science|1991
2k cit.
6
High Capacity Anode Materials for Rechargeable Sodium-Ion Batteries
Journal of The Electrochemical Society|2000
1.8k cit.
7
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Genome Research|2012
1.8k cit.
8
The Mechanisms of Lithium and Sodium Insertion in Carbon Materials
Journal of The Electrochemical Society|2001
1.5k cit.
9
Misconduct accounts for the majority of retracted scientific publications
Proceedings of the National Academy of Sciences|2012
1.2k cit.
10
Topographic diversity of fungal and bacterial communities in human skin
Nature|2013
1.2k cit.

Reagents for Nail Diseases and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

S100A9 (D5O6O) Rabbit Monoclonal Antibody (IHC Formulated)

#34425$168,369
View Evidence →
Cell Signaling TechnologyEvidence 65

LAG3 (D2G4O) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#87220$465
View Evidence →
Cell Signaling TechnologyEvidence 67

ADAR1 (E6X9R) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#99623$465
View Evidence →

🌟 All-Time

Most validated

New England Biolabs

Oligo d(T)₁₈ mRNA Primer

#S1316S$92
View Evidence →
New England Biolabs

Random Primer Mix

#S1330S$99
View Evidence →
Cell Signaling Technology

Apolipoprotein C-I (F9L6S) Rabbit Monoclonal Antibody

#92796$161,376
View Evidence →